IC Value-Added Distribution Business Market, Global Outlook and Forecast 2023-2029
Price : US $3250 | Date : May 2023 |
CAT ID : 8 | Pages : 97 |
The global Site-directed Mutagenesis Service market was valued at US$ 1002.2 million in 2022 and is projected to reach US$ 1372.4 million by 2029, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Site-directed mutagenesis is a widely used technique in molecular biology and genetic engineering that allows researchers to introduce specific changes or mutations into a DNA sequence.
Site-directed mutagenesis services are provided by various companies and research institutions to support scientific research, drug development, and other applications requiring precise modifications to DNA sequences. These services often involve the design and synthesis of custom DNA templates with specific mutations or modifications requested by the client.
The market status and future development trends of the site-directed mutagenesis service market include the following:
Increasing Demand: With advancements in genetic research and biotechnology applications, there is a growing demand for site-directed mutagenesis services. Researchers in academia, pharmaceutical companies, and biotech firms rely on these services to create specific genetic variants for functional studies, protein engineering, therapeutic development, and other research purposes.
Customization and Specialization: As the field of genetics becomes more specialized, site-directed mutagenesis service providers may focus on offering tailored solutions to meet the specific needs of different research areas or industries. This could involve expertise in specific organisms, gene families, or targeted genetic modifications.
Automation and High-throughput Capabilities: To improve efficiency and cost-effectiveness, site-directed mutagenesis services may adopt automation and high-throughput technologies. This allows for the simultaneous generation of multiple mutations or modifications in a faster and more streamlined manner.
Quality Assurance and Validation: Given the critical nature of site-directed mutagenesis in research and product development, there is an increasing emphasis on quality control, validation, and rigorous quality assurance measures by service providers. This ensures accurate and reliable results, which are essential for downstream applications.
Integration with Other Services: Site-directed mutagenesis services may be integrated with other molecular biology services or techniques to offer comprehensive solutions. For example, providers may offer sequencing, gene synthesis, or cloning services alongside site-directed mutagenesis to facilitate a seamless workflow for researchers.
Regulatory Compliance: As the applications of site-directed mutagenesis expand into areas like gene therapy or agricultural biotechnology, adherence to regulatory guidelines and ethical considerations will become increasingly important.
This report aims to provide a comprehensive presentation of the global market for Site-directed Mutagenesis Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Site-directed Mutagenesis Service. This report contains market size and forecasts of Site-directed Mutagenesis Service in global, including the following market information:
Global Site-directed Mutagenesis Service Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Site-directed Mutagenesis Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Site-directed Mutagenesis Service Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Site-directed Mutagenesis Service Market Segment Percentages, by Type, 2022 (%)
Standard Site-directed Mutagenesis Service
Customized Site-directed Mutagenesis Service
Global Site-directed Mutagenesis Service Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Site-directed Mutagenesis Service Market Segment Percentages, by Application, 2022 (%)
Scientific Research
Gene Therapy
Cell Therapy
Others
Global Site-directed Mutagenesis Service Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Site-directed Mutagenesis Service Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Site-directed Mutagenesis Service revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Site-directed Mutagenesis Service revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GenScript
Eurofins
Applied Biological Materials
Azenta Life Sciences
Thermo Fisher Scientific
Bon Opus Biosciences
Charles Rive
Creative Biogene
Synbio Technologies
Creative Biolabs
NovoPro
Bionexus
Biotech Desk
NorClone
Eton Bioscience
Syd Labs
Genosphere Biotechnologies
WZ Biosciences
FulenGen
GENEWIZ
iGene Biotechnology
Tsingke
AtaGenix
Zoonbio Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Site-directed Mutagenesis Service, market overview.
Chapter 2: Global Site-directed Mutagenesis Service market size in revenue.
Chapter 3: Detailed analysis of Site-directed Mutagenesis Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Site-directed Mutagenesis Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Site-directed Mutagenesis Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Site-directed Mutagenesis Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Site-directed Mutagenesis Service Overall Market Size
2.1 Global Site-directed Mutagenesis Service Market Size: 2022 VS 2029
2.2 Global Site-directed Mutagenesis Service Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Site-directed Mutagenesis Service Players in Global Market
3.2 Top Global Site-directed Mutagenesis Service Companies Ranked by Revenue
3.3 Global Site-directed Mutagenesis Service Revenue by Companies
3.4 Top 3 and Top 5 Site-directed Mutagenesis Service Companies in Global Market, by Revenue in 2022
3.5 Global Companies Site-directed Mutagenesis Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Site-directed Mutagenesis Service Players in Global Market
3.6.1 List of Global Tier 1 Site-directed Mutagenesis Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Site-directed Mutagenesis Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Site-directed Mutagenesis Service Market Size Markets, 2022 & 2029
4.1.2 Standard Site-directed Mutagenesis Service
4.1.3 Customized Site-directed Mutagenesis Service
4.2 By Type - Global Site-directed Mutagenesis Service Revenue & Forecasts
4.2.1 By Type - Global Site-directed Mutagenesis Service Revenue, 2018-2023
4.2.2 By Type - Global Site-directed Mutagenesis Service Revenue, 2024-2029
4.2.3 By Type - Global Site-directed Mutagenesis Service Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Site-directed Mutagenesis Service Market Size, 2022 & 2029
5.1.2 Scientific Research
5.1.3 Gene Therapy
5.1.4 Cell Therapy
5.1.5 Others
5.2 By Application - Global Site-directed Mutagenesis Service Revenue & Forecasts
5.2.1 By Application - Global Site-directed Mutagenesis Service Revenue, 2018-2023
5.2.2 By Application - Global Site-directed Mutagenesis Service Revenue, 2024-2029
5.2.3 By Application - Global Site-directed Mutagenesis Service Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Site-directed Mutagenesis Service Market Size, 2022 & 2029
6.2 By Region - Global Site-directed Mutagenesis Service Revenue & Forecasts
6.2.1 By Region - Global Site-directed Mutagenesis Service Revenue, 2018-2023
6.2.2 By Region - Global Site-directed Mutagenesis Service Revenue, 2024-2029
6.2.3 By Region - Global Site-directed Mutagenesis Service Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Site-directed Mutagenesis Service Revenue, 2018-2029
6.3.2 US Site-directed Mutagenesis Service Market Size, 2018-2029
6.3.3 Canada Site-directed Mutagenesis Service Market Size, 2018-2029
6.3.4 Mexico Site-directed Mutagenesis Service Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Site-directed Mutagenesis Service Revenue, 2018-2029
6.4.2 Germany Site-directed Mutagenesis Service Market Size, 2018-2029
6.4.3 France Site-directed Mutagenesis Service Market Size, 2018-2029
6.4.4 U.K. Site-directed Mutagenesis Service Market Size, 2018-2029
6.4.5 Italy Site-directed Mutagenesis Service Market Size, 2018-2029
6.4.6 Russia Site-directed Mutagenesis Service Market Size, 2018-2029
6.4.7 Nordic Countries Site-directed Mutagenesis Service Market Size, 2018-2029
6.4.8 Benelux Site-directed Mutagenesis Service Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Site-directed Mutagenesis Service Revenue, 2018-2029
6.5.2 China Site-directed Mutagenesis Service Market Size, 2018-2029
6.5.3 Japan Site-directed Mutagenesis Service Market Size, 2018-2029
6.5.4 South Korea Site-directed Mutagenesis Service Market Size, 2018-2029
6.5.5 Southeast Asia Site-directed Mutagenesis Service Market Size, 2018-2029
6.5.6 India Site-directed Mutagenesis Service Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Site-directed Mutagenesis Service Revenue, 2018-2029
6.6.2 Brazil Site-directed Mutagenesis Service Market Size, 2018-2029
6.6.3 Argentina Site-directed Mutagenesis Service Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Site-directed Mutagenesis Service Revenue, 2018-2029
6.7.2 Turkey Site-directed Mutagenesis Service Market Size, 2018-2029
6.7.3 Israel Site-directed Mutagenesis Service Market Size, 2018-2029
6.7.4 Saudi Arabia Site-directed Mutagenesis Service Market Size, 2018-2029
6.7.5 UAE Site-directed Mutagenesis Service Market Size, 2018-2029
7 Site-directed Mutagenesis Service Companies Profiles
7.1 GenScript
7.1.1 GenScript Company Summary
7.1.2 GenScript Business Overview
7.1.3 GenScript Site-directed Mutagenesis Service Major Product Offerings
7.1.4 GenScript Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.1.5 GenScript Key News & Latest Developments
7.2 Eurofins
7.2.1 Eurofins Company Summary
7.2.2 Eurofins Business Overview
7.2.3 Eurofins Site-directed Mutagenesis Service Major Product Offerings
7.2.4 Eurofins Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.2.5 Eurofins Key News & Latest Developments
7.3 Applied Biological Materials
7.3.1 Applied Biological Materials Company Summary
7.3.2 Applied Biological Materials Business Overview
7.3.3 Applied Biological Materials Site-directed Mutagenesis Service Major Product Offerings
7.3.4 Applied Biological Materials Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.3.5 Applied Biological Materials Key News & Latest Developments
7.4 Azenta Life Sciences
7.4.1 Azenta Life Sciences Company Summary
7.4.2 Azenta Life Sciences Business Overview
7.4.3 Azenta Life Sciences Site-directed Mutagenesis Service Major Product Offerings
7.4.4 Azenta Life Sciences Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.4.5 Azenta Life Sciences Key News & Latest Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Summary
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific Site-directed Mutagenesis Service Major Product Offerings
7.5.4 Thermo Fisher Scientific Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.5.5 Thermo Fisher Scientific Key News & Latest Developments
7.6 Bon Opus Biosciences
7.6.1 Bon Opus Biosciences Company Summary
7.6.2 Bon Opus Biosciences Business Overview
7.6.3 Bon Opus Biosciences Site-directed Mutagenesis Service Major Product Offerings
7.6.4 Bon Opus Biosciences Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.6.5 Bon Opus Biosciences Key News & Latest Developments
7.7 Charles Rive
7.7.1 Charles Rive Company Summary
7.7.2 Charles Rive Business Overview
7.7.3 Charles Rive Site-directed Mutagenesis Service Major Product Offerings
7.7.4 Charles Rive Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.7.5 Charles Rive Key News & Latest Developments
7.8 Creative Biogene
7.8.1 Creative Biogene Company Summary
7.8.2 Creative Biogene Business Overview
7.8.3 Creative Biogene Site-directed Mutagenesis Service Major Product Offerings
7.8.4 Creative Biogene Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.8.5 Creative Biogene Key News & Latest Developments
7.9 Synbio Technologies
7.9.1 Synbio Technologies Company Summary
7.9.2 Synbio Technologies Business Overview
7.9.3 Synbio Technologies Site-directed Mutagenesis Service Major Product Offerings
7.9.4 Synbio Technologies Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.9.5 Synbio Technologies Key News & Latest Developments
7.10 Creative Biolabs
7.10.1 Creative Biolabs Company Summary
7.10.2 Creative Biolabs Business Overview
7.10.3 Creative Biolabs Site-directed Mutagenesis Service Major Product Offerings
7.10.4 Creative Biolabs Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.10.5 Creative Biolabs Key News & Latest Developments
7.11 NovoPro
7.11.1 NovoPro Company Summary
7.11.2 NovoPro Business Overview
7.11.3 NovoPro Site-directed Mutagenesis Service Major Product Offerings
7.11.4 NovoPro Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.11.5 NovoPro Key News & Latest Developments
7.12 Bionexus
7.12.1 Bionexus Company Summary
7.12.2 Bionexus Business Overview
7.12.3 Bionexus Site-directed Mutagenesis Service Major Product Offerings
7.12.4 Bionexus Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.12.5 Bionexus Key News & Latest Developments
7.13 Biotech Desk
7.13.1 Biotech Desk Company Summary
7.13.2 Biotech Desk Business Overview
7.13.3 Biotech Desk Site-directed Mutagenesis Service Major Product Offerings
7.13.4 Biotech Desk Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.13.5 Biotech Desk Key News & Latest Developments
7.14 NorClone
7.14.1 NorClone Company Summary
7.14.2 NorClone Business Overview
7.14.3 NorClone Site-directed Mutagenesis Service Major Product Offerings
7.14.4 NorClone Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.14.5 NorClone Key News & Latest Developments
7.15 Eton Bioscience
7.15.1 Eton Bioscience Company Summary
7.15.2 Eton Bioscience Business Overview
7.15.3 Eton Bioscience Site-directed Mutagenesis Service Major Product Offerings
7.15.4 Eton Bioscience Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.15.5 Eton Bioscience Key News & Latest Developments
7.16 Syd Labs
7.16.1 Syd Labs Company Summary
7.16.2 Syd Labs Business Overview
7.16.3 Syd Labs Site-directed Mutagenesis Service Major Product Offerings
7.16.4 Syd Labs Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.16.5 Syd Labs Key News & Latest Developments
7.17 Genosphere Biotechnologies
7.17.1 Genosphere Biotechnologies Company Summary
7.17.2 Genosphere Biotechnologies Business Overview
7.17.3 Genosphere Biotechnologies Site-directed Mutagenesis Service Major Product Offerings
7.17.4 Genosphere Biotechnologies Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.17.5 Genosphere Biotechnologies Key News & Latest Developments
7.18 WZ Biosciences
7.18.1 WZ Biosciences Company Summary
7.18.2 WZ Biosciences Business Overview
7.18.3 WZ Biosciences Site-directed Mutagenesis Service Major Product Offerings
7.18.4 WZ Biosciences Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.18.5 WZ Biosciences Key News & Latest Developments
7.19 FulenGen
7.19.1 FulenGen Company Summary
7.19.2 FulenGen Business Overview
7.19.3 FulenGen Site-directed Mutagenesis Service Major Product Offerings
7.19.4 FulenGen Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.19.5 FulenGen Key News & Latest Developments
7.20 GENEWIZ
7.20.1 GENEWIZ Company Summary
7.20.2 GENEWIZ Business Overview
7.20.3 GENEWIZ Site-directed Mutagenesis Service Major Product Offerings
7.20.4 GENEWIZ Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.20.5 GENEWIZ Key News & Latest Developments
7.21 iGene Biotechnology
7.21.1 iGene Biotechnology Company Summary
7.21.2 iGene Biotechnology Business Overview
7.21.3 iGene Biotechnology Site-directed Mutagenesis Service Major Product Offerings
7.21.4 iGene Biotechnology Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.21.5 iGene Biotechnology Key News & Latest Developments
7.22 Tsingke
7.22.1 Tsingke Company Summary
7.22.2 Tsingke Business Overview
7.22.3 Tsingke Site-directed Mutagenesis Service Major Product Offerings
7.22.4 Tsingke Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.22.5 Tsingke Key News & Latest Developments
7.23 AtaGenix
7.23.1 AtaGenix Company Summary
7.23.2 AtaGenix Business Overview
7.23.3 AtaGenix Site-directed Mutagenesis Service Major Product Offerings
7.23.4 AtaGenix Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.23.5 AtaGenix Key News & Latest Developments
7.24 Zoonbio Biotechnology
7.24.1 Zoonbio Biotechnology Company Summary
7.24.2 Zoonbio Biotechnology Business Overview
7.24.3 Zoonbio Biotechnology Site-directed Mutagenesis Service Major Product Offerings
7.24.4 Zoonbio Biotechnology Site-directed Mutagenesis Service Revenue in Global Market (2018-2023)
7.24.5 Zoonbio Biotechnology Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Price : US $3250 | Date : May 2023 |
CAT ID : 8 | Pages : 97 |
Price : US $3250 | Date : May 2023 |
CAT ID : 8 | Pages : 144 |
Price : US $3250 | Date : May 2023 |
CAT ID : 8 | Pages : 131 |
Price : US $3250 | Date : May 2023 |
CAT ID : 8 | Pages : 113 |
Price : US $3250 | Date : May 2023 |
CAT ID : 8 | Pages : 92 |
24/7 Research support
Quality assurance
Information security